World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
22598
World Ranking
15725
National Ranking
7915

Luka Milas publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Luka Milas sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 369 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Luka Milas D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Luka Milas sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Luka Milas is affiliated with The University of Texas MD Anderson Cancer Center in the United States. This association situates them within a leading institution known for cancer research and treatment. Their scientific work is connected to this environment, which often focuses on oncological and biomedical studies.

There are no recent papers or specific publication titles available for Luka Milas. Consequently, detailed information about the scope and content of their research articles cannot be provided.

No information is available on frequent co-authors, indicating either independent work or a lack of publicly recorded collaborative patterns in the accessible data.

The data also does not list any frequent publication venues, so it is not possible to specify the journals or conferences where Luka Milas tends to publish scientific findings.

Similarly, there are no recorded book publications, which suggests that the scientist has not contributed to academic books in a manner documented in the source data.

Details about Luka Milas' main fields of study, subfields, and research topics are absent. Without this, it is not possible to outline their exact scientific specialties or the thematic areas of their work.

No awards or honors are recorded in the data. This implies that no specific recognitions have been noted or indexed within the available records.

Luka Milas is currently living, which allows for the possibility of ongoing research activities and contributions in their field.

Best Publications

  • Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

    K. Kian Ang;Brian A. Berkey;Xiaoyu Tu;Hua Zhong Zhang

  • Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

    Klaus Dittmann;Claus Mayer;Birgit Fehrenbacher;Martin Schaller

  • In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

    Luka Milas;Kathy Mason;Nancy Hunter;Sven Petersen

  • Complete Regression of Well-established Tumors Using a Novel Water-soluble Poly(l-Glutamic Acid)-Paclitaxel Conjugate

    Chun Li;Dong Fang Yu;Robert A. Newman;Fernando Cabral

  • Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas

    Tetsuo Akimoto;Nancy R. Hunter;Lara Buchmiller;Kathy Mason

  • The epidermal growth factor receptor mediates radioresistance.

    Ke Liang;K.Kian Ang;Luka Milas;Nancy Hunter

  • Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.

    Kazushi Kishi;Sven Petersen;Cordula Petersen;Nancy Hunter

  • Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

    Luka Milas;Kazushi Kishi;Nancy Hunter;Kathryn Mason

  • Sensitization of breast cancer cells to radiation by trastuzumab.

    Ke Liang;Yang Lu;Weidong Jin;K. Kian Ang

  • Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.

    R. E. Meyn;L. C. Stephens;Kie-Kian Ang;N. R. Hunter

  • Apoptosis in irradiated murine tumors.

    L. C. Stephens;K. K. Ang;T. E. Schultheiss;L. Milas

  • Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.

    Cordula Petersen;Sven Petersen;Luka Milas;Frederick F. Lang

  • Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.

    Luka Milas;Nancy R. Hunter;Belma Kurdoglu;Kathryn A. Mason

  • Tissue tolerance to reirradiation

    Carsten Nieder;Luka Milas;K. Kian Ang

  • Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

    Christopher Crane;James L. Abbruzzese;Douglas B. Evans;Robert A Wolff

  • Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

    Hak Choy;Luka Milas

  • Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.

    Luka Milas;Zhen Fan;Nicolaus H. Andratschke;K.Kian Ang

  • Enhancement of tumor radioresponse in vivo by gemcitabine

    Luka Milas;Takashi Fujii;Takashi Fujii;Nancy Hunter;Mohamed Elshaikh

  • Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non–small-cell lung cancer: report of a randomized comparative trial

    Ritsuko Komaki;Jin Soo Lee;Luka Milas;Hoon K. Lee

  • Single Nucleotide Polymorphism at rs1982073:T869C of the TGFβ1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Definitive Radiotherapy

    Xianglin Yuan;Zhongxing Liao;Zhensheng Liu;Li E. Wang

Frequent Co-Authors

K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
Raymond E. Meyn
Raymond E. Meyn The University of Texas MD Anderson Cancer Center
James D. Cox
James D. Cox The University of Texas MD Anderson Cancer Center
Pamela K. Allen
Pamela K. Allen The University of Texas MD Anderson Cancer Center
Sidney Wallace
Sidney Wallace The University of Texas MD Anderson Cancer Center
Walter N. Hittelman
Walter N. Hittelman The University of Texas MD Anderson Cancer Center
Lester J. Peters
Lester J. Peters Peter MacCallum Cancer Centre
Howard D. Thames
Howard D. Thames The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn’t always mean pursuing the traditional MD path. In fact, healthcare offers a wide range of online degrees and flexible career options to fit diverse goals and backgrounds.

For registered nurses, advancing your education with a BSN can be both convenient and affordable. Learn more about the average cost of rn to bsn programs to discover cost-effective ways to expand your qualifications.

If you don’t have a nursing background but want to quickly enter advanced nursing roles, consider the growing number of msn direct entry programs online. These accelerated programs are designed especially for non-nursing graduates seeking a fast track into the nursing profession.

Those new to healthcare might start with the adn programs, which provide a shorter and often more accessible path to becoming a registered nurse.

Alternatively, if you’re interested in the administrative side of healthcare, there are excellent options for medical billing and coding online schools that accept financial aid, opening the door to remote career opportunities without patient care duties.

Best Scientists Citing Luka Milas